These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33086885)

  • 1. Perceptions, attitudes, and behaviors of short-acting beta
    Azzi E; Kritikos V; Peters M; Price D; Cvetkovski B; Alphonse PS; Bosnic-Anticevich S
    J Asthma; 2022 Jan; 59(1):178-188. PubMed ID: 33086885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding reliever overuse in patients purchasing over-the-counter short-acting beta
    Azzi EA; Kritikos V; Peters MJ; Price DB; Srour P; Cvetkovski B; Bosnic-Anticevich S
    BMJ Open; 2019 Aug; 9(8):e028995. PubMed ID: 31412998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-acting β
    Visser CD; Faay MRA; Özdemir A; Guchelaar HJ; Teichert M
    Respir Med; 2024 Sep; 231():107723. PubMed ID: 38936636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association Between Short-Acting β
    Price D; Jenkins C; Hancock K; Vella R; Heraud F; Le Cheng P; Murray R; Beekman M; Bosnic-Anticevich S; Botini F; Carter V; Catanzariti A; Doan J; Fletton K; Kichkin A; Le T; Le Lievre C; Lau CM; Novic D; Pakos J; Ranasinghe K; Roussos A; Samuel-King J; Sharma A; Stewart D; Willet B; Bateman E;
    Adv Ther; 2024 Mar; 41(3):1262-1283. PubMed ID: 38310584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions, attitudes, and behaviors of asthma patients towards the use of short-acting β2-agonists: A systematic review.
    Loh ZC; Hussain R; Balan S; Saini B; Muneswarao J; Ong SC; Babar ZU
    PLoS One; 2023; 18(4):e0283876. PubMed ID: 37079594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Reliever Inhaler Users and Asthma Control: A Cross-Sectional Multicenter Study in Portuguese Community Pharmacies.
    Romão M; Godinho AR; Teixeira PM; Mendes Z; Bernardo F; Teixeira Rodrigues A; Correia de Sousa J
    J Asthma Allergy; 2021; 14():943-954. PubMed ID: 34354362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-prescription of short-acting β
    Chakaya J; Mecha J; Beekman M
    BMC Prim Care; 2023 Jul; 24(1):141. PubMed ID: 37422638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-prescription of short-acting β
    Smith C; Ambaram A; Mitha E; Abdullah I; Abdullah IA; Reddy J; Trokis J; Ramlachan P; Govind U; Lightfoot K; Moodley K; Smit R; Beekman MJHI
    Afr J Thorac Crit Care Med; 2022; 28(4):. PubMed ID: 36874189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overprescription of short-acting β
    Al Zaabi A; Busaidi N; Al Mutairy S; Yorgancıoğlu A; Aksu K; Al-Jahdali H; Wali S; Elsayed M; Beekman MJ
    Expert Rev Respir Med; 2022 Jul; 16(7):833-847. PubMed ID: 35848074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overprescription of short-acting β
    Al-Jahdali H; Wali S; Albanna AS; Al Harbi A; Allehebi R; Arwadi A; Dahan T; Fattouh M; Hamza E; Beekman M
    Clin Respir J; 2022 Dec; 16(12):812-825. PubMed ID: 36279888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-the-counter β2-agonist purchase versus script: a cross-sectional study.
    Douglass JA; Goeman DP; McCarthy EA; Sawyer SM; Aroni RA; Stewart K; Abramson MJ
    Respir Med; 2012 Feb; 106(2):223-9. PubMed ID: 22040532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Burden of Short-Acting β
    Di Marco F; D'Amato M; Lombardo FP; Micheletto C; Heiman F; Pegoraro V; Boarino S; Manna G; Mastromauro F; Spennato S; Papi A
    Adv Ther; 2021 Jul; 38(7):3816-3830. PubMed ID: 34043208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-acting β
    Bateman ED; Price DB; Wang HC; Khattab A; Schonffeldt P; Catanzariti A; van der Valk RJP; Beekman MJHI
    Eur Respir J; 2022 May; 59(5):. PubMed ID: 34561293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with high short-acting β2-agonist use in urban children with asthma.
    Butz AM; Ogborn J; Mudd S; Ballreich J; Tsoukleris M; Kub J; Bellin M; Bollinger ME
    Ann Allergy Asthma Immunol; 2015 May; 114(5):385-92. PubMed ID: 25840499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-prescription of short-acting β
    Alzaabi A; Al Busaidi N; Pradhan R; Shandy F; Ibrahim N; Ashtar M; Khudadah K; Hegazy K; Samir M; Negm M; Farouk H; Al Khalidi A; Beekman M
    Asthma Res Pract; 2022 Jul; 8(1):3. PubMed ID: 35799290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study.
    van den Berg LN; Hallensleben C; Vlug LA; Chavannes NH; Versluis A
    JMIR Hum Factors; 2024 Apr; 11():e54386. PubMed ID: 38574348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the Community.
    Alamyar S; Azzi E; Srour-Alphonse P; House R; Cvetkovski B; Kritikos V; Bosnic-Anticevich S
    Pharmacy (Basel); 2023 Jul; 11(4):. PubMed ID: 37489346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks associated with managing asthma without a preventer: urgent healthcare, poor asthma control and over-the-counter reliever use in a cross-sectional population survey.
    Reddel HK; Ampon RD; Sawyer SM; Peters MJ
    BMJ Open; 2017 Sep; 7(9):e016688. PubMed ID: 28947448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-prescription of short-acting β
    Montero-Arias F; Garcia JCH; Gallego MP; Antila MA; Schonffeldt P; Mattarucco WJ; Gallegos LFT; Beekman MJHI
    J Asthma; 2023 Mar; 60(3):574-587. PubMed ID: 35670783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world patterns and implications of short-acting β
    Lugogo N; Gilbert I; Tkacz J; Gandhi H; Goshi N; Lanz MJ
    Ann Allergy Asthma Immunol; 2021 Jun; 126(6):681-689.e1. PubMed ID: 33515710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.